Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class? - Reply
Contributors
Meier, Raphaël; Rizzoli, René; Peter, RobinPublished in
JAMA internal medicine, vol. 173, no. 1, 80Publication date
2013Keywords
- Diphosphonates/adverse effects
- Femoral Fractures/etiology
- Humans
UNIGE research groups
Citation (ISO format)
MEIER, Raphaël, RIZZOLI, René, PETER, Robin. Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class? - Reply. In: JAMA internal medicine, 2013, vol. 173, n° 1, p. 80. doi: 10.1001/jamainternmed.2013.1238
Main files (1)
Article (Published version)
Identifiers
- PID : unige:30007
- DOI : 10.1001/jamainternmed.2013.1238
- PMID : 23318594
